Determination of sample size including the factor of σD [Power / Sample Size]

posted by junhao – China, 2016-07-08 06:34 (3645 d 12:24 ago) – Posting: # 16480
Views: 9,422

Hello everybody,

In Table 1, Appendix C of FDA 2001 guidance Statistical Approaches to Establishing Bioequivalence, the sample size is calculated for different σDs. I was wondering how this is done? Nothing can I find in the two references listed with the talbe.

One further question, when power.RSABE() of R package TOST is used in simulation that gives sample size for RSABE design, does it account for σD, or the σD is assumed to be zero?

In a previous post, A reference is mentioned:

Scott D Patterson and Byron Jones
REPLICATE DESIGNS AND AVERAGE, INDIVIDUAL, AND POPULATION BIOEQUIVALENCE
GSK BDS Technical Report 2002 – 01

A link was given below but I failed opening it :lookaround:. Can somebody help to try if this link is still correct?
http://biometrics.com/wp-content/uploads/2009/06/tr2002-01.pdf

Thank you,

Junhao//

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
350 visitors (0 registered, 350 guests [including 16 identified bots]).
Forum time: 18:59 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5